Primaxin, Recarbrio (imipenem) is a small molecule pharmaceutical. Imipenem was first approved as Primaxin on 1985-11-26. It is used to treat bacterial endocarditis, bacterial infections, enterobacteriaceae infections, infectious bone diseases, and intraabdominal infections amongst others in the USA. It has been approved in Europe to treat gram-negative bacterial infections.
|Indication||bacterial endocarditis, bacterial infections, enterobacteriaceae infections, gram-negative bacterial infections, infectious bone diseases, intraabdominal infections, pelvic infection, pseudomonas infections, respiratory tract infections, staphylococcal infections, streptococcal infections, urinary tract infections|
|Drug Class||Antibacterial antibiotics, carbapenem derivatives|